Aptose Biosciences
APTO
#10448
Rank
A$6.52 M
Marketcap
A$2.56
Share price
0.00%
Change (1 day)
649.28%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -A$31.68 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$37.71 Million, an increase over its 2023 earnings that were of -A$78.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$31.68 Million-16%
2024 -A$37.71 Million-51.82%
2023 -A$78.28 Million22.9%
2022 -A$63.69 Million-34.91%
2021 -A$97.85 Million17.36%
2020 -A$83.38 Million107.65%
2019 -A$40.16 Million-7.73%
2018 -A$43.52 Million160.68%
2017 -A$16.7 Million-20.27%
2016 -A$20.94 Million28.71%
2015 -A$16.27 Million
2013 -A$9.23 Million
2010 -A$7.86 Million-8.31%
2009 -A$8.57 Million
2006 -A$15.89 Million-156.93%
2005 A$27.89 M-185.16%
2004 -A$32.76 Million458.58%
2003 -A$5.87 Million-63.66%
2002 -A$16.14 Million-8.04%
2001 -A$17.55 Million16.73%
2000 -A$15.04 Million294.99%
1999 -A$3.81 Million-6.51%
1998 -A$4.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-A$50.87 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-A$0.11 Billion 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-A$93.86 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA